173 related articles for article (PubMed ID: 24265754)
1. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression.
Zhang M; Luo W; Huang B; Liu Z; Sun L; Zhang Q; Qiu X; Xu K; Wang E
PLoS One; 2013; 8(11):e79173. PubMed ID: 24265754
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer.
Li H; Sun L; Tang Z; Fu L; Xu Y; Li Z; Luo W; Qiu X; Wang E
PLoS One; 2012; 7(5):e37657. PubMed ID: 22666376
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
4. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.
Murakami M; Giampietro C; Giannotta M; Corada M; Torselli I; Orsenigo F; Cocito A; d'Ario G; Mazzarol G; Confalonieri S; Di Fiore PP; Dejana E
PLoS One; 2011; 6(6):e21242. PubMed ID: 21695058
[TBL] [Abstract][Full Text] [Related]
6. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
7. JAM-C promotes lymphangiogenesis and nodal metastasis in non-small cell lung cancer.
Hao S; Yang Y; Liu Y; Yang S; Wang G; Xiao J; Liu H
Tumour Biol; 2014 Jun; 35(6):5675-87. PubMed ID: 24584816
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
Li H; Sun L; Xu Y; Li Z; Luo W; Tang Z; Qiu X; Wang E
PLoS One; 2013; 8(6):e66679. PubMed ID: 23840517
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
Li X; Zhang Q; Fan K; Li B; Li H; Qi H; Guo J; Cao Y; Sun H
Int J Mol Sci; 2016 Mar; 17(4):437. PubMed ID: 27023518
[TBL] [Abstract][Full Text] [Related]
10. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.
Lampis A; Hahne JC; Gasparini P; Cascione L; Hedayat S; Vlachogiannis G; Murgia C; Fontana E; Edwards J; Horgan PG; Terracciano L; Sansom OJ; Martins CD; Kramer-Marek G; Croce CM; Braconi C; Fassan M; Valeri N
Cell Death Differ; 2021 Oct; 28(10):2970-2982. PubMed ID: 34226680
[TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression.
She Y; Han Y; Zhou G; Jia F; Yang T; Shen Z
Cancer Genet; 2020 Feb; 241():12-19. PubMed ID: 31962276
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression.
Li Z; Qu L; Dong Q; Huang B; Li H; Tang Z; Xu Y; Luo W; Liu L; Qiu X; Wang E
PLoS One; 2012; 7(5):e36903. PubMed ID: 22615840
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma.
Magara K; Takasawa A; Osanai M; Ota M; Tagami Y; Ono Y; Takasawa K; Murata M; Hirohashi Y; Miyajima M; Yamada G; Hasegawa T; Sawada N
Cancer Sci; 2017 Nov; 108(11):2306-2314. PubMed ID: 28837251
[TBL] [Abstract][Full Text] [Related]
15. Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation.
Ay AS; Benzerdjeb N; Sevestre H; Ahidouch A; Ouadid-Ahidouch H
PLoS One; 2013; 8(9):e72889. PubMed ID: 24058448
[TBL] [Abstract][Full Text] [Related]
16. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
18. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression.
Sun Y; Yang C; Chen J; Song X; Li Z; Duan M; Li J; Hu X; Wu K; Yan G; Yang C; Liu J; Tan W; Ye M
J Cell Mol Med; 2016 Apr; 20(4):698-709. PubMed ID: 26849396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
